(AVUS) Avantis U.S. Equity - Ratings and Ratios
U.S. Stocks, Equity Securities, Futures Contracts, Swap Agreements
Description: AVUS Avantis U.S. Equity
The Avantis U.S. Equity ETF (AVUS) is a diversified investment vehicle that focuses on U.S. companies across various market sectors and industry groups, without limiting itself to specific market capitalizations. This broad investment approach allows the fund to capture a wide range of market opportunities.
From a portfolio construction perspective, the fund adheres to a strategy where at least 80% of its assets are allocated to equity securities of U.S. companies under normal market conditions. Additionally, it utilizes derivative instruments such as futures contracts, currency forwards, and swap agreements to potentially enhance returns or manage risk.
To further analyze the funds performance, key metrics such as tracking error, information ratio, and Sharpe ratio can be considered. A low tracking error relative to its benchmark would indicate that the fund is effectively mirroring the market segment it is designed to represent. The information ratio, which measures risk-adjusted returns relative to the benchmark, can provide insight into the funds ability to generate excess returns. The Sharpe ratio, assessing returns in excess of the risk-free rate relative to volatility, can help evaluate the funds risk-adjusted performance.
Given its AUM of $8.96 billion, AVUS has a substantial presence in the market, suggesting a certain level of liquidity and potentially lower trading costs for investors. To assess its investment efficiency, metrics like turnover rate and expense ratio are crucial. A lower expense ratio indicates lower costs for investors, while a reasonable turnover rate can imply a balance between active management and cost control.
Additional Sources for AVUS ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
AVUS ETF Overview
Market Cap in USD | 8,923m |
Category | Large Blend |
TER | 0.15% |
IPO / Inception | 2019-09-24 |
AVUS ETF Ratings
Growth Rating | 70.6 |
Fundamental | - |
Dividend Rating | 62.1 |
Rel. Strength | -2.16 |
Analysts | - |
Fair Price Momentum | 97.03 USD |
Fair Price DCF | - |
AVUS Dividends
Dividend Yield 12m | 1.28% |
Yield on Cost 5y | 2.51% |
Annual Growth 5y | 10.39% |
Payout Consistency | 100.0% |
Payout Ratio | % |
AVUS Growth Ratios
Growth Correlation 3m | 93.2% |
Growth Correlation 12m | 40.1% |
Growth Correlation 5y | 83.6% |
CAGR 5y | 15.17% |
CAGR/Max DD 5y | 0.68 |
Sharpe Ratio 12m | 0.95 |
Alpha | -2.61 |
Beta | 0.997 |
Volatility | 13.41% |
Current Volume | 704.5k |
Average Volume 20d | 241.3k |
Stop Loss | 99.8 (-3%) |
As of August 08, 2025, the stock is trading at USD 102.92 with a total of 704,490 shares traded.
Over the past week, the price has changed by -0.17%, over one month by +1.17%, over three months by +12.27% and over the past year by +20.75%.
Yes. Based on ValueRay's Analyses, Avantis U.S. Equity (NYSE ARCA:AVUS) is currently (August 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.59 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AVUS is around 97.03 USD . This means that AVUS is currently overvalued and has a potential downside of -5.72%.
Avantis U.S. Equity has no consensus analysts rating.
According to our own proprietary Forecast Model, AVUS Avantis U.S. Equity will be worth about 116.4 in August 2026. The stock is currently trading at 102.92. This means that the stock has a potential upside of +13.14%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 116.4 | 13.1% |